Joint Statement on Breast Implant Associated Squamous Cell Carcinoma and other Breast Implant Associated Lymphomas
20th July 2023
This statement is provided jointly by the British Association of Aesthetic Plastic Surgeons (BAAPS), the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) and the Association of Breast Surgery (ABS) to give information on what is known, and recommendations for practice in the United Kingdom following a USA FDA (Food and Drug Administration) Safety Alert on 8th September 2022.1
The report described a number of cases of extremely uncommon cancers associated with breast implant capsules. The cancers were squamous cell carcinomas (BIA-SCC), and various lymphomas. These were not breast cancers, but cancers that arose in the surrounding capsule (scar tissue) of breast implants.
Click here to continue reading the entire statement including initial recommendations for patients and for surgeons.
Back to list page